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24p3 is a secreted protein that induces apoptosis in leukocytes. Recently, 24p3 has been 
shown to bind to iron-containing bacterial siderophores. In this issue of Cell, Devireddy et 
al. (2005) identify a receptor that internalizes 24p3. Internalization of iron bound to 24p3 
prevents apoptosis. In contrast, internalization of the apo form of 24p3 that does not contain 
iron leads to cellular iron efflux and apoptosis via the proapoptotic protein Bim.The chemical properties of iron, 
which make it both malleable and 
strong, have shaped human history. 
Nature itself uses the flexible chem-
istry of iron in many crucial metabolic 
reactions, such as the synthesis of 
ATP and DNA. Due to the role of iron 
in cellular proliferation, iron chelators 
are agents that may be useful for the 
treatment of cancer (for review see 
Richardson [2005]). Hence, a com-
prehensive knowledge of iron metab-
olism is essential for understanding 
basic biological processes such as 
growth and organogenesis.
The study of iron metabolism can 
be roughly divided into “old” and 
“new” iron ages. The literature of the 
old iron age teaches that iron is first 
bound by transferrin, the serum iron 
transport molecule. Iron bound trans-
ferrin binds to the transferrin receptor-
1 (TfR1), which is then internalized by 
receptor-mediated endocytosis (Rich-
ardson, 2005). Iron is released from 
transferrin by low endosomal pH and 
transported across the membrane 
and into the cell where it is incorpo-
rated into the iron-storage protein, 
ferritin. The relative levels of TfR1 and 
ferritin are regulated posttranscrip-
tionally by iron, at least in part through 
iron-regulatory proteins 1 and 2.
In the past decade, we have wit-
nessed a new iron age with the 
remarkable discovery of additional 
molecules that play crucial roles in 
iron metabolism. These proteins include the hemochromatosis gene 
product (HFE), the divalent metal 
transporter-1 (DMT1), transferrin 
receptor-2, hephaestin, ferroportin-
1, hepcidin and hemojuvelin (Rich-
ardson, 2005). As part of the new 
iron age, recent attention also has 
focused on the lipocalin 24p3 (also 
called lipocalin-2 or uterocalin in mice 
and neutrophil-gelatinase-associated 
lipocalin [NGAL] in humans). Lipo-
calins are small secreted proteins that 
bind to low-molecular-weight ligands 
and play roles in many processes 
including olfaction, retinol transport, 
and prostaglandin synthesis. In this 
issue of Cell, Green and colleagues 
(Devireddy et al., 2005) describe the 
cloning of the receptor for 24p3 called 
24p3R. The DNA sequence of this 
molecule matched a database entry 
proposed to encode a murine brain-
type organic cation transporter (NM_
021551). This molecule is highly con-
served in humans and is predicted to 
have twelve transmembrane helices. 
The authors suggest a link between 
iron internalization mediated by 24p3R 
and the regulation of apoptosis.
As a strategy against infection, 
mammalian cells sequester iron to 
prevent it from being used for bacterial 
growth. Several lipocalins (lipocalin-1 
and 24p3) bind to iron through the 
ligation of bacterial catecholate and 
mycobacterial siderophores (small-
molecular-weight chelators) such as 
enterobactin (Goetz et al., 2002; Flo Cell 123, Deceet al., 2004; Fluckinger et al., 2004; 
Holmes et al., 2005). Lipocalin-1 and 
24p3 act during the acute phase of 
the innate immune response (Flo et 
al., 2004) and bolster the defense 
provided by transferrin and lactoferrin, 
which bind to “free iron.” Interestingly, 
mice lacking 24p3 display no pheno-
type under pathogen-free conditions, 
but upon exposure to sublethal doses 
of Escherichia coli H9049, these 
24p3-deficient mice were far more 
likely to develop bacteremia (Flo et 
al., 2004).
In addition to the role of lipocalin-
1 and 24p3 in innate immunity, it 
has also been reported that 24p3 is 
involved in kidney development as an 
iron-donating molecule (Yang et al., 
2002). Intriguingly, 24p3 was originally 
purified as a protein that promotes the 
mesenchymal to epithelial conversion 
of ureteric bud cell lines. This effect 
could potentially be related to the 
ability of 24p3 to donate iron to cells 
(Yang et al., 2003). It was suggested 
that 24p3 could bind to iron and then 
deliver it to the cell through a process 
requiring endocytosis and endosomal 
acidification, although this pathway 
differed from that used by transferrin 
(Yang et al., 2002). Furthermore, 24p3 
may be taken up by primordial epithe-
lial and stromal cells, whereas trans-
ferrin is internalized by later-stage 
epithelial cells (Yang et al., 2002). 
This led to the proposal that 24p3 
may be an iron donor, independent of mber 29, 2005 ©2005 Elsevier Inc. 1175
Figure 1. Possible Effects of Holo-24p3 and Apo-24p3 on Iron Metabolism and Apoptosis
(A) Holo-24p3 containing the iron complex of the bacterial siderophore, enterobactin, donates iron to cells via the 24p3 receptor (24p3R; Devireddy et 
al., 2005). Internalization of 24p3 and its receptor leads to the uptake of iron from the siderophore-iron complex. Although the exact mechanism remains 
unclear, Yang et al. (2002) describe a process that requires acidification of an endosomal-like compartment and the potential transport of the released iron 
via the DMT1. Donation of iron to the cell leads to a decrease in TfR1 expression and an increase in ferritin levels (Richardson, 2005). In addition, donation 
of iron to the cell prevents apoptosis by decreasing the expression of the proapoptotic protein Bim.
(B) Apo-24p3 binds to 24p3R and is internalized into the cell. However, it is not known whether this route is different from that taken by holo-24p3. Devi-
reddy and colleagues (2005) suggest that a putative intracellular mammalian “siderophore” iron complex becomes bound to apo-24p3 to form holo-24p3, 
which is subsequently released from the cell by exocytosis. Depletion of iron from the cell results in the upregulation of the proapoptotic molecule, Bim, 
which leads to apoptosis. The putative intracellular mammalian siderophore has not yet been characterized and remains speculative.the transferrin-TfR1 pathway, which is 
vital for early embryonic development 
(Levi et al., 1999).
A link has been established between 
apoptosis and the level of iron within 
the cell (Richardson, 2005), and 
intriguing results have implicated 
24p3 in apoptosis (Devireddy et al., 
2001). It is well known that apopto-
sis can be triggered by the depletion 
of specific trophic factors, such as 
the withdrawal of interleukin-3 from 
hematopoietic cells. In fact, secreted 
24p3 can induce apoptosis upon the 
withdrawal of interleukin-3 (Devireddy 
et al., 2001). For the first time, Devi-
reddy and colleagues (2005) describe 
a mechanism by which mouse 24p3 
donates iron to cells and prevents 
apoptosis (Figure 1A). The authors 1176 Cell 123, December 29, 2005 ©2005suggest that the effects of 24p3 are 
dependent upon whether this protein 
contains iron or not. Bound to the 
holo form of 24p3 is the iron complex 
of the bacterial siderophore, entero-
bactin, whereas the apo form does 
not contain this complex. Interest-
ingly, the receptor for 24p3, 24p3R, 
is reported to bind to both apo- and 
holo-24p3 and enables their internal-
ization by endocytosis (Figure 1).
The 24p3R mediates the ability 
of the holo-form of 24p3 to donate 
iron to cells and prevent apoptosis 
(Figure 1A). In contrast, the internal-
ization of apo-24p3 by cells leads to 
iron efflux that results in apoptosis 
and cell death, which is mediated by 
the proapoptotic protein Bim (Figure 
1B). Hence, the effect of apo-24p3 is  Elsevier Inc.reminiscent of the action of cytotoxic 
iron chelators, which bind to iron and 
induce apoptosis (Richardson, 2005). 
The authors suggest a model in which 
internalized apo-24p3 binds to iron 
within the cell from a hypothetical 
mammalian siderophore. The holo-
24p3 that is subsequently generated 
is then released by exocytosis (Devi-
reddy et al., 2005).
Although the mechanism of uptake 
of holo-24p3 by 24p3R is reminiscent 
of the uptake of iron from holo-trans-
ferrin by the TfR1 (Richardson, 2005), 
there are also some distinct differ-
ences. The uptake of transferrin by 
the TfR1 is largely dependent on the 
iron status of the protein—the affin-
ity of TfR1 for holo-transferrin is far 
greater than its affinity for apo-trans-
ferrin (Richardson, 2005). In contrast, 
although the affinity of 24p3R for 
apo- and holo-24p3 was not mea-
sured, Devireddy et al. (2005) indicate 
that both apo- and holo-24p3 can be 
bound and internalized by 24p3R, but 
each results in dramatically different 
biological consequences (Figures 
1A and 1B). At present, it is unclear 
whether apo- and holo-24p3 bound 
to the 24p3R are sorted along the 
same intracellular trafficking pathway. 
The apo-24p3 that is generated when 
holo-24p3 donates its iron for metab-
olism would be expected to undergo 
exocytosis (Figure 1A). Yet, it is unclear 
whether this occurs. Presumably the 
apo form would be receptive to the 
iron-donating properties of the puta-
tive intracellular mammalian sidero-
phore. Interestingly, a previous study 
did suggest that 24p3 was recycled 
after donating iron to the cell (Yang et 
al., 2002). Further studies are needed 
to determine whether holo- and apo-
24p3 compete for 24p3R binding and 
whether they follow similar or different 
intracellular trafficking routes.
Surprisingly, Devireddy and col-
leagues (2005) also present evidence 
indicating that the BCR-ABL oncop-
rotein increases expression of apo-
NGAL (the human homolog of 24p3) 
and at the same time represses the 
expression of its receptor (NGALR), 
resulting in cells that are unrespon-
sive to secreted apo-NGAL. Treat-
ment of cells with the BCR-ABL inhib-
itor, imatinib, resulted in upregulation 
of the NGALR, thereby rendering the 
cells sensitive to apo-NGAL-mediated 
apoptosis. This suggests a mecha-
nism for how imatinib mediates apop-
tosis in cells that express BCR-ABL. 
The effect of imatinib was prevented 
by the addition of iron or holo-trans-
ferrin, which decreased Bim expres-
sion, thereby linking the pathways 
of iron metabolism and apoptosis. 
These results may be relevant to the 
treatment of chronic myelogenous leukemia (CML) with imatinib. Leu-
kemic lymphoblasts from a limited 
number of untreated CML patients 
were shown to express high levels of 
apo-NGAL but not NGALR, whereas 
normal peripheral blood lymphocytes 
express high levels of the NGALR but 
only low levels of apo-NGAL (Devi-
reddy et al., 2005). The authors sug-
gest that the secretion of apo-NGAL 
from BCR-ABL-expressing leukemic 
lymphoblasts may contribute to the 
severity and progression of CML by 
interfering with normal hematopoie-
sis. However, further studies are nec-
essary to confirm this hypothesis.
While the study by Devireddy et 
al. (2005) is intriguing and provides 
a basis for further experimentation, 
there are some vital caveats that need 
to be discussed. First, the 24p3 iron 
uptake pathway is not essential for 
organogenesis or development, as 
deletion of this gene results in viable 
adult mice (Flo et al., 2004). Second, 
the mammalian “siderophore” that 
potentially binds to apo-24p3 and is 
involved in iron efflux (Figure 1B) has 
not been identified. Although there 
have been reports of siderophore-like 
growth factors from transformed cells 
(Fernandez-Pol, 1978) and normal tis-
sues (Jones et al., 1980), these find-
ings remain isolated and unconfirmed. 
Moreover, there is no evidence of 
large quantities of low-molecular-
weight iron within mammalian cells 
that would be available to bind to apo-
24p3 (Richardson, 2005). Third, Devi-
reddy and colleagues (2005) have 
used 24p3 loaded with iron bound to 
the bacterial siderophore, enterobac-
tin, to investigate iron uptake by mam-
malian cells. Although the 24p3-sid-
erophore complex has relevance to 
the pathological state of bacteremia 
(Flo et al., 2004), it is not relevant to 
physiological conditions such as early 
embryonic development, where pro-
karyotic siderophores are absent.
The iron uptake process reported Cell 123, Deceby Devireddy and associates (2005) 
may be representative of a clear-
ance mechanism that leads to the 
uptake and metabolism of bacterial 
siderophores bound to 24p3, but its 
relevance to normal cellular physiol-
ogy remains unclear. The challenge 
for further studies is to isolate the 
putative mammalian siderophore, to 
determine whether 24p3 represents a 
physiologically-relevant mechanism of 
iron uptake, and to confirm its mem-
bership in the new iron age.
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